Compare · GMED vs ZBH
GMED vs ZBH
Side-by-side comparison of Globus Medical Inc. (GMED) and Zimmer Biomet Holdings Inc. (ZBH): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both companies sit in the Health Care sector. GMED focuses on Medical/Dental Instruments, while ZBH focuses on Industrial Specialties.
- ZBH is the larger of the two at $19.55B, about 2.1x GMED ($9.34B).
- ZBH has been more active in the news (16 items in the past 4 weeks vs 9 for GMED).
- Both have 25 recent analyst ratings on file.
- Company
- Globus Medical Inc.
- Zimmer Biomet Holdings Inc.
- Price
- -
- -
- Market cap
- $9.34B
- $19.55B
- 1M return
- -
- +7.66%
- 1Y return
- -
- +15.52%
- Industry
- Medical/Dental Instruments
- Industrial Specialties
- Exchange
- NYSE
- NYSE
- IPO
- 2012
- News (4w)
- 9
- 16
- Recent ratings
- 25
- 25
Globus Medical Inc.
Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders. Its offers spine products, such as consists of traditional fusion implants, such as pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative, deformity, tumors, and trauma conditions; treatment options for motion preservation technologies, such as dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional pain management solutions to treat vertebral compression fractures; and regenerative biologic products, comprising of allografts and synthetic alternatives. The company also offers products for the treatment of orthopedic trauma, including fracture plates, compression screws, intramedullary nails, and external fixation systems; and hip and knee joint solutions, including modular hip stems and acetabular cups, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants. In addition, it distributes human cell, tissue, and cellular and tissue based products; and COALITION, COALITION MIS, COALITION AGX, MONUMENT, MAGNIFY-S, HEDRON IATM, HEDRON ICTM, INDEPENDENCE, INDEPENDENCE MIS, FORTIFY and XPAND families, SABLETM, RISE, RISE INTRALIF, RISE-L, ELSA, ELSA ATP, RASS, ALTERA, ARIEL, LATIS, CALIBER and CALIBER-L products. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.
Zimmer Biomet Holdings Inc.
Zimmer Biomet Holdings, Inc., together with its subsidiaries, designs, manufactures, and markets musculoskeletal healthcare products and solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company provides orthopaedic reconstructive products, such as knee and hip replacement products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; spine products comprising medical devices and surgical instruments; and face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open heart surgery, trauma, or for deformities of the chest. It also offers dental products that include dental reconstructive implants, and dental prosthetic and regenerative products, as well as surgical, bone cement, and office-based technology products. The company's products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopedic surgeons, neurosurgeons, oral surgeons, dentists, hospitals, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.
Latest GMED
- Director Tobin James R exercised 41,666 shares at a strike of $56.30 and sold $3,131,547 worth of shares (41,666 units at $75.16) (SEC Form 4)
- SEC Form 144 filed by Globus Medical Inc.
- Globus Medical to Participate in Jefferies Global Healthcare Conference
- Globus Medical downgraded by BMO Capital Markets with a new price target
- Director Rhoads Ann D sold $425,000 worth of shares (5,000 units at $85.00) as part of a pre-agreed trading plan, decreasing direct ownership by 12% to 35,384 units (SEC Form 4)
- SEC Form 10-Q filed by Globus Medical Inc.
- Globus Medical Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Other Events, Financial Statements and Exhibits
- Globus Medical Reports Third Quarter 2026 Results and Announces a $500 Million Increase to the Share Repurchase Program
- Globus Medical Acquires Synaptive Medical, Strengthening Its Position in Cranial Neurosurgery
- Globus Medical Schedules Third Quarter Earnings Release and Conference Call
Latest ZBH
- Zimmer Biomet upgraded by Wells Fargo with a new price target
- SEC Form CERT filed by Zimmer Biomet Holdings Inc.
- SEC Form 8-A12B filed by Zimmer Biomet Holdings Inc.
- Zimmer Biomet Holdings Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits
- SEC Form 424B5 filed by Zimmer Biomet Holdings Inc.
- SEC Form 424B5 filed by Zimmer Biomet Holdings Inc.
- Zimmer Biomet to Present at the Annual Jefferies Global Healthcare Conference in London
- Zimmer Biomet Introduces Surgeon-Guided Autonomy, a New Category in Intelligent Surgery
- SEC Form FWP filed by Zimmer Biomet Holdings Inc.
- SEC Form FWP filed by Zimmer Biomet Holdings Inc.